L-type calcium channels mediate depolarizationinduced calcium influx in insulin-secreting cells and are thought to be modulated by G proteincoupled receptors (GPCRs). The major fraction of L-type ␣ 1 -subunits in pancreatic ␤-cells is of the neuroendocrine subtype (Ca V 1.3 or ␣ 1D ). Here we studied the biophysical properties and receptor regulation of a Ca V 1.3 subunit previously cloned from HIT-T15 cells. In doing so, we compared this neuroendocrine Ca V 1.3 channel with the cardiac L-type channel Ca V 1.2a (or ␣ 1C-a ) after expression together with ␣ 2 ␦-and ␤ 3 -subunits in Xenopus oocytes. Both the current voltage relation and voltage dependence of inactivation for the neuroendocrine Ca V 1.3 channel were shifted to more negative potentials compared with the cardiac Ca V 1.2 channel. In addition, the Ca V 1.3 channel activated and inactivated more rapidly than the Ca V 1.2a channel. Both subtypes showed a similar sensitivity to the dihydropyridine (؉)isradipine. More interestingly, the Ca V 1.3 channels were found to be stimulated by ligand-bound G i /G o -coupled GPCRs whereas a neuronal Ca V 2.2 (or ␣ 1B ) channel was inhibited. The observed receptor-induced stimulation of Ca V 1.3 channels could be mimicked by phorbol-12-myristate-13-acetate and was sensitive to inhibitors of protein kinases, but not to the phosphoinositol-3-kinase-inhibitor wortmannin, pointing to serine/ threonine kinase-dependent regulation. Taken together, we describe a neuroendocrine L-type 
INTRODUCTION
Voltage-dependent calcium channels play a central role in the regulation of insulin secretion by pancreatic ␤-cells. However, the subtypes of calcium channels involved, their particular contribution to the secretion process, and their regulation by glucose and by transmitter substances are still controversial points. This is due, in part, to the fact that studies have been performed on native ␤-cells from different species and also on various insulin-secreting cell lines, e.g. HITcells and RINm5F cells.
Using molecular biological approaches, various pore-forming calcium channel ␣ 1 -subunits (Ca V 1.2, Ca V 1.3, Ca V 2.1, Ca V 2.2, Ca V 2.3, and Ca V 3.1) have been identified in insulin-secreting cells and pancreatic tissue (1) (2) (3) (4) (5) . In electrophysiological studies, channel currents with the pharmacological and functional properties known for these subunits have also been reported. Thus, high-voltage-activated (HVA), dihydropyridine (DHP)-sensitive channels (6) , corresponding to the Ca V 1.2 or Ca V 1.3 subunits, -conotoxin GVIAsensitive channels (7, 8) , corresponding to the Ca V 2.2 subunit, and -agatoxin IVA-sensitive channels (5), corresponding to the Ca V 2.1 subunit, have been de-scribed. Low-voltage-activated currents, which would correspond to the Ca V 3.1 subunit that has been found in the INS-1 cell line, have also been observed in several insulin-secreting cell types (4) .
Taken together, insulin-secreting cells express multiple voltage-gated calcium channel subtypes, making it difficult to clarify the properties of a certain channel type in these cells. A common approach to address this problem is the use of cellular systems overexpressing the proteins of interest. This approach has already been extensively used to study the properties of channels formed by most of the calcium channel ␣ 1 -subunits [e.g. Ca V 1.2 (9, 10), Ca V 2.1 (11), Ca V 2.2 (9, 12, 13) , Ca V 2.3 (11, 14) ; Ca V 3.1 (15, 16) ].
In the case of the Ca V 1.3 subunit, however, which is thought to play a major role in the regulation of insulin secretion, few data are available (17, 18) , although several splice variants were cloned (17) (18) (19) (20) . This subunit, in combination with the auxiliary subunits ␣ 2 ␦ and ␤, forms an HVA-calcium channel of the L-type (for review see Refs. [21] [22] [23] . Its occurrence is not restricted to the pancreas. Isoforms of the Ca V 1.3 subunit have been identified by RT-PCR, antibodies, or Northern blot analysis in brain, heart, kidney, adrenal gland, and osteoblasts (24) (25) (26) . Ca V 1.3 is thought to comprise the major fraction of L-type calcium current in neurosecretory and neuronal cells (Refs. 22 and 27 but see also Ref. 25) .
In pancreatic ␤-cells the majority of L-type calcium channel mRNA codes for Ca V 1.3 subunits (2, 28) . So far, there is only a single brief report on the functional expression of a Ca V 1.3 channel cloned from an insulin secreting cell line [RINm5F (17) ]. Hence, data on the functional properties and regulation of these neuroendocrine Ca V 1.3-derived pore-forming calcium channel subunits are still lacking. This prompted us to study the Ca V 1.3 isoform cloned from the insulin-secreting HIT-T15 cell line (19) , after coexpression with the ␣ 2 ␦ and ␤ 3 subunits in Xenopus oocytes. Here, we provide the first description of the biophysical properties of this isoform and the first description of receptor regulation of a heterologously expressed pancreatic Ca V 1.3 channel.
RESULTS

Calcium Channel Expression
To examine the functional properties of calcium channels, we injected ␣ 1 subunits encoding the neuroendocrine (Ca V 1.3), cardiac (Ca V 1.2a), or neuronal (Ca V 2.2) calcium channel together with the ␣ 2 ␦ and ␤ 3 subunits into oocytes. The resulting Ba 2ϩ inward current amplitudes in subsequent voltage-clamp measurements were highly variable (Fig. 1A ). Differences were considerable between individual donor toads, but much less within a batch of oocytes from the same animal. Uninjected oocytes showed either no detectable native calcium channel current, or inward currents with amplitudes of up to 50 nA. In oocyte batches from most donor animals, endogenous oocyte calcium channel currents were enhanced by exogenous ␣ 2 ␦ and ␤ subunits, as described previously (29) . The resulting currents were often of considerable amplitude (see Fig. 1A ), in agreement with one previous study (29) , but in contrast to others (18, 30) . Hereafter, the ␤/␣ 2 ␦-stimulated endogenous oocyte calcium channel is referred to as the endogenous calcium channel. To assess the effects on endogenous channels, all types of experiments on inward Ba 2ϩ currents were also performed in cells injected with cRNA for the ␣ 2 ␦ and ␤ subunits. To minimize the contribution of currents through the endogenous channel, the amplitudes of currents through these channels were compared with those from cells injected with cRNA for the respective complete exogenous channel. Only those oocyte batches were used, in which a very large relative proportion (at least 80%) of total current was contributed by the exogenous channel subtype. Up to 20% of endogenous current was present in some cases when examining the Ca V 1.3 channel, since the amplitude of currents in oocytes expressing this channel was in general smaller than that in those expressing the cardiac Ca V 1.2a or neuronal Ca V 2.2 subunits (compare Fig. 1A ). These latter two ␣ 1 subunits produced large currents, which were usually measurable on the second day after cRNA injection. In contrast, expression of the neuroendocrine Ca V 1.3 calcium channel exceeded expression of the endogenous channel to a sufficient extent for measurement only after 4-6 days.
When expressed without the auxiliary subunits ␣ 2 ␦ and ␤ (n ϭ 8), the neuroendocrine Ca V 1.3 subunit did not produce inward currents exceeding those of noninjected oocytes, in contrast to the Ca V 1.2a subunit (our unpublished data and Ref. 31). Currents of larger amplitude than those in control cells were also not observed when only ␣ 2 ␦ was expressed together with Ca V 1.3. In contrast, when the ␤ 3 subunit was coexpressed with Ca V 1.3 without ␣ 2 ␦, the resulting current amplitudes were 22-50% of the corresponding Ca V 1.3/␤ 3 /␣ 2 ␦ currents. In one batch of oocytes that did not display measurable endogenous calcium channel currents after injection of exogenous auxiliary subunits, the following maximum inward current amplitudes were obtained: Ca V 1.3: 0 nA (n ϭ 4), Ca V 1.3/ ␤ 3 : Ϫ152 Ϯ 29 nA (n ϭ 6), Ca V 1.3/␤ 3 /␣ 2 ␦: Ϫ586 Ϯ 141 nA (n ϭ 6).
Activation of Ba 2؉ Currents
Analysis of the current-voltage (I-V) relationships for the neuroendocrine Ca V 1.3 and the cardiac Ca V 1.2a channels (Fig. 1B ) revealed significant differences with respect to the half-maximal activation parameters (V 1/2 ; P Ͻ 0.05) , which were Ϫ9.6 Ϯ 1.2 mV (n ϭ 17) and Ϫ6.1 Ϯ 1.2 mV (n ϭ 17), but not for the slope factors (k), which were 7.5 Ϯ 0.2 mV and 7.3 Ϯ 0.4 mV, respectively. The maximum inward current for the neu-roendocrine Ca V 1.3 channel occurred at more negative potentials (2.7 Ϯ 1.1 mV; n ϭ 14) than for the cardiac Ca V 1.2a channel (6.4 Ϯ 1.1 mV; P Ͻ 0.05). The I-V relation of the endogenous calcium channel showed a V 1/2 that was significantly (P Ͻ 0.001) shifted to depolarized potentials compared with the Ca V 1.3 and the Ca V 1.2a channels. Half-maximal activation occurred at 9.4 Ϯ 1.1 mV, and the slope factor (k) was estimated to be 7.5 Ϯ 0.4 mV. The maximum inward current was at 18.8 Ϯ 1.0 mV, a value comparable to those published previously (10, 18, 31) . It is obvious from the current traces in Fig. 1C that the activation of the cardiac Ca V 1.2a channel is slower than that of the neuroendocrine Ca V 1.3 or endogenous counterparts. The rising phase of currents elicited by depolarizing voltage steps was quantified by determining the time necessary to reach 90% of peak current [90% time-to-peak (ttp)] in each case ( Fig. 2A) . The cardiac Ca V 1.2a calcium channel showed a significantly (P Ͻ 0.05) slower activation compared with the neuroendocrine Ca V 1.3 and the endogenous channel over the voltage range between Ϫ10 and ϩ20 mV. The activation times for the neuroendocrine Ca V 1.3 and the endogenous oocyte channels were only significantly different (P Ͻ 0.05) at Ϫ10 mV. In addition, a voltage dependence of the values for 90% ttp was observed for all three channels with values decreasing with increasing depolarization. This decrease with potential was, however, only significant (P Ͻ 0.05) for the neuroendocrine Ca V 1.3 and the cardiac Ca V 1.2a channels, when the values of 90% ttp at the different voltages were compared for each individual subtype. Comparing fits of a monoexponential function to currents during 1,500-msec pulses to the maximum of the individual I-V curve (see Fig. 2B ), was 546 Ϯ 23 msec (n ϭ 17) for the neuroendocrine Ca V 1.3 and 972 Ϯ 126 msec (n ϭ 9) for the cardiac Ca V 1.2a calcium channel, values that were significantly different (P Ͻ 0.001; see also Fig. 2B ). Since endogenous oocyte Ca 2ϩ -activated Cl Ϫ conductances may obscure the measurement of inactivation of calcium channels, additional experiments were performed on oocytes with the calcium chelator BAPTA [1,2-bis(oamino-5-bromophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid, sodium] present inside the cell. The currents during 1,500-msec pulses to the maximum of the individual I-V curve fitted with a monoexponential function, was 530 Ϯ 15 msec (n ϭ 26) for the neuroendocrine Ca V 1.3 and 966 Ϯ 88 msec (n ϭ 14) for the cardiac Ca V 1.2a calcium channel, values that were significantly different (P Ͻ 0.001). Hence, the rate of inactivation of Ca V 1.2a channels was significantly different from inactivation of Ca V 1.3 channels, both in the presence and absence of the intracellular Ca 2ϩ chelator BAPTA.
Inactivation of
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Current Inactivation
The steady-state inactivation was measured with a two-step protocol. The inactivation curves are shown A, Time-to-90% peak current (90% ttp) during voltage pulses to the indicated potentials for the neuroendocrine Ca V 1.3 (n ϭ 5), the cardiac Ca V 1.2a (n ϭ 5), and the endogenous oocyte (n ϭ 5) calcium channel. B, Channel inactivation during 1,500 msec voltage steps to the maximum of the individual I-V curve. Traces were normalized to the maximum current and a representative example is shown for each case. C, Steady-state inactivation data were deduced from peak currents at 0 mV reached after a prepulse to the indicated potentials. Data were pooled from experiments with prepulse lengths between 10 and 90 sec; no significant differences were observed between the differing protocols. The prepulse and the test pulse were separated by a 10-to 20-msec interval at Ϫ80 mV. Individual inactivation curves were normalized to the maximum current, averaged, and fitted, yielding a half-maximal inactivation at Ϫ37.1 mV for the Ca V 1.3 (Ⅺ; n ϭ 24), Ϫ24.7 mV for the cardiac Ca V 1.2a (E; n ϭ 20), and Ϫ38.5 mV for the endogenous (; n ϭ 7) calcium channel.
in Fig. 2C . Their analysis indicated that the cardiac Ca V 1.2a and the neuroendocrine Ca V 1.3 channels differ significantly (P Ͻ 0.001) in their half-maximal inactivation, with respective V 1/2 values of Ϫ22.7 Ϯ 1.7 (n ϭ 20) and Ϫ36.1 Ϯ 0.9 mV (n ϭ 24). Values for the endogenous calcium channel (V 1/2 ϭ Ϫ35.0 Ϯ 3.5 mV; n ϭ 7) differed significantly from both other channels (P ϭ 0.001). The slope factor (k) was almost identical for all three channels (neuroendocrine Ca V 1.3: 12.7 Ϯ 0.3 mV; cardiac Ca V 1.2a: 14.0 Ϯ 0.7 mV; and endogenous: 14.4 Ϯ 1.2 mV).
In addition, we analyzed steady-state inactivation in the presence of intracellular BAPTA. The results also showed a significant difference (P Ͻ 0.001) between the cardiac Ca V 1.2a channel (V 1/2 ϭ Ϫ20.5 Ϯ 2.3 mV; n ϭ 15) and the neuroendocrine Ca V 1.3 channel (V 1/2 ϭ Ϫ30.9 Ϯ 1.2 mV; n ϭ 17).
Current Characterization by Blocking Agents
HVA calcium currents in native ␤-cells have been shown to be blocked completely by 200 M Cd 2ϩ (8) . Addition of 200 M Cd 2ϩ to the bath solution abolished currents through the Ca V 1.3/␤ 3 /␣ 2 ␦ (n ϭ 6) as well as the Ca V 1.2a/␤ 3 /␣ 2 ␦ (n ϭ 4) calcium channels.
An important distinguishing feature for L-type calcium channels is their sensitivity to DHPs. We therefore compared the DHP sensitivity of the neuroendocrine Ca V 1.3, cardiac Ca V 1.2a, and endogenous channels. Using (ϩ)isradipine (Fig. 3 ), we found a 50% inhibition of the DHP-sensitive fraction of the current at a concentration of 43 nM for the cardiac Ca V 1.2a channel and a similar value of 57 nM for the neuroendocrine Ca V 1.3 channel. The endogenous current was not inhibited by (ϩ)isradipine at concentrations up to 3 M (n ϭ 7), as also shown in other studies (31, 32).
Regulation of the Expressed Calcium Channels
Previously, we and others have found a G proteindependent inhibition of L-type calcium channels in neuroendocrine cells (7, 33 , 34) resembling membrane-delimited inhibition of calcium channel ␣ 1A,B,Esubunits by G␤␥-complexes (12, 35, 36) . Furthermore, the neuroendocrine Ca V 1.3 calcium channel subtype, in particular, has been proposed to be affected by this inhibition (for review see Ref. 22) . This prompted us to examine the regulation of the neuroendocrine Ca V 1.3 channel from HIT-T15 cells in oocytes coinjected with the G i /G o -coupled -opioid receptor. In our hands, this receptor was able to couple to endogenous phospholipase C in oocytes, as indicated by the stimulation of calcium-dependent chloride currents (n ϭ 14) after receptor activation with the selective -opioid receptor agonist DAMGO ([D-Ala 2 ,NMe-Phe 4 ,Gly-ol 5 ]-enkephalin) in oocytes bathed in modified Ringer. Furthermore, we have ascertained that the -opioid receptor used in this study couples only to pertussis toxin-sensitive G proteins of the G isubfamily regardless of which agonist was used (37). Moreover, as a control for G protein-mediated inhibition in this system, we tested the neuronal (N-type) Ca V 2.2 (or ␣ 1B ) calcium channel. This channel is the classical example of a voltage-dependent calcium channel inhibited by PT-sensitive G proteins (38, 39). As depicted in Fig. 4 , application of DAMGO to oocytes coexpressing -opioid receptors and Ca V 2.2 channels resulted in a rapid inhibition of inward currents. The concentration of DAMGO necessary to maximally inhibit this channel was determined from the dose-response relation, which revealed an IC 50 of 
Currents with a duration of 5 sec derived from voltage steps to the potential of peak current amplitude in the individual I-V curves could be best fitted by a biexponential function, resulting in a fast ( 1 ) and a slow ( 2 ) inactivating component. The term A 1 /A 2 gives the relation between the maximal current amplitudes of the components. For the neuroendocrine Ca V 1.3 channel: n ϭ 5; cardiac Ca V 1.2a: n ϭ 5; endogenous: n ϭ 5. Characteristics and Regulation of a Ca V 1.3 Ca 2ϩ Channel1.1 nM and maximal inhibition with concentrations above 100 nM (n ϭ 3-5). This maximal inhibition was approximately 60%, in accordance with previous studies of this channel when expressed with calcium channel ␤ subunits (9, 40) . In contrast to the neuronal Ca V 2.2, the neuroendocrine Ca V 1.3 channel was stimulated by DAMGO at a maximally effective concentration (1 M). The effect started within a few seconds of agonist application, reached a maximum increase of 406 Ϯ 49 nA (28 Ϯ 2%, n ϭ 20) within 2 min, and was reversible upon washout of the agonist (see Fig. 4 ). To exclude nonspecific, receptor-independent effects, DAMGO was applied at the same concentration to cells injected with cRNA for the neuroendocrine Ca V 1.3 channel, but not for the -opioid receptor. No stimulation of inward current was observed (n ϭ 5) under these conditions or after the application of bath solution without DAMGO to cells expressing the -opioid receptor and neuroendocrine Ca V 1.3 channel (n ϭ 3). Since it was shown by Zamponi et al. (40) that G protein-mediated inhibition can be impaired as a result of channel phosphorylation by protein kinase C (PKC), oocytes were incubated with H7 at a high concentration (100 M) to inhibit serine/threonine kinasedependent phosphorylation as completely as possible (Fig. 4B) . After 5 min (n ϭ 3) or 30 min (n ϭ 2) of preincubation with H7, the increase in current through the neuroendocrine Ca V 1.3 channel after opioid receptor activation was prevented. However, under these conditions DAMGO still failed to induce calcium channel inhibition (see Fig. 4B ). We therefore concluded that DAMGO-induced neuroendocrine Ca V 1.3 calcium channel stimulation involved protein phosphorylation. Stimulation of calcium channel currents in neuroendocrine cells resulting from phosphorylation by protein kinase A (PKA) and PKC has been reported in several studies (41, 42). Since PKA can also be inhibited by H7 (43), we tested the effect of PKA inhibition on receptor-stimulated channel activity. The response of the neuroendocrine Ca V 1.3 calcium channel to receptor activation in oocytes injected with the PKA-inhibitor Rp-cAMPS (adenosine 3Ј,5Ј-cyclic phosphorothiolate-Rp) [to calculated final concentrations of 50 M (n ϭ 4) and 400 M (n ϭ 5), 15-20 min before experiments], did not significantly differ from that in control cells without Rp-cAMPS (n ϭ 9). Since L-type calcium channels are known to be stimulated by G protein-coupled receptors (GPCRs) in a phosphoinositol-3-kinase (PI3K)-and/or PKC-dependent manner, we tested the effects of the PI3K-inhibitor wortmannin and the PKC-inhibitor bisindolylmaleimide I on calcium current stimulation. Incubation of oocytes with 150 nM and 500 nM wortmannin in the extracellular solution for 20 min did not result in a significant reduction of the DAMGO-induced effect (n ϭ 5). In contrast, preincubation of oocytes with bisindolylmaleimide I (100 nM, 1 h) resulted in a significant reduction of DAMGO-induced calcium current stimulation (P Ͻ 0.005; Fig. 4B ). Furthermore, we used the phorbol ester phorbol myristate acetate (PMA) to directly activate PKC and obviate potential complications due to overlapping inhibitory effects via G i/o proteins and stimulatory effects via PKC on calcium channel activity. In line with the results obtained with DAMGO, acute application of PMA (100 nM; n ϭ 12) increased the Ba 2ϩ inward current (107.5 Ϯ 13.4 nA, n ϭ 12) significantly within 2.5 min when compared with results from experiments with vehicle only (46.7 Ϯ 11.1 nA, n ϭ 9) in cells overexpressing the neuroendocrine Ca V 1.3 channel (P Ͻ 0.005).
It should be mentioned that the endogenous oocyte calcium channel was also stimulated by DAMGO. Even though this stimulation was pronounced (200 Ϯ 21%), the absolute amplitude of the effect and the A, Typical current amplitude measurements representing peak currents at voltage steps to 0 mV are shown for the Ca V 1.3 (Ⅺ), the endogenous oocyte (), and the neuronal (OE) calcium channel. The pulse frequency was 0.2 Hz. B, Maximum current changes under DAMGO application (2.5 min) for the neuronal (n ϭ 7), the endogenous (n ϭ 23), and the neuroendocrine Ca V 1.3 (n ϭ 26) calcium channel. The fourth column shows the DAMGO effect on the neuroendocrine Ca V 1.3 channel after preincubation with H7 (100 M; n ϭ 5); the fifth column shows the DAMGO effect on this channel after preincubation with bisindolylmaleimide I (Bis I; 100 nM; n ϭ 5). Both inhibitors were also present during the DAMGO application in the respective experiments. kinetics of this stimulation allowed a clear distinction between the responses of the neuroendocrine Ca V 1.3 and the endogenous channel (see Fig. 4 ). After agonist application, the increase in currents through the endogenous channel started with a delay, reaching a maximum usually during washout of the agonist (see Fig. 4 ). Since no current stimulation occurred in the presence of H7, stimulation of the endogenous channel probably results from protein phosphorylation. This observation is also in agreement with those that showed that the amplitude of currents through the endogenous oocyte calcium channel was increased by PMA (Ref. 32 and our unpublished data).
DISCUSSION
Here we describe the successful expression of a previously cloned neuroendocrine L-type calcium channel consisting of the Ca V 1.3 subunit from insulin-secreting cells together with the ␤ 3 and ␣ 2 ␦ subunits (19) . Channels of this subunit combination are likely to occur in native endocrine cells since Ca V 1.3, ␤ 2 , and ␤ 3 have been found to coincide in RINm5F cells (17) . Furthermore, studies using in situ hybridization and immunostaining found a colocalization of Ca V 1.3 and ␤ 3 in several brain areas (44) .
Notably, currents through this neuroendocrine channel were not observed upon expression of the Ca V 1.3 subunit alone or in combination with ␣ 2 ␦. Hence, its association with at least ␤ subunits seem to be essential for functional expression, as also reported for two other Ca V 1.3 isoforms (17, 18) . Nevertheless, upon coexpression of ␣ 2 ␦ with the Ca V 1.3/␤ 3 subunits, the amplitude of neuroendocrine Ca V 1.3 channel currents was increased by 2-to 5-fold in the present study. Similar effects of the ␣ 2 ␦ subunit on the Ca V 2.1/␤ combination were reported by de Waard and Campbell (30), who found a 2.5-fold current increase. An even more pronounced effect (ϳ15-fold stimulation) was also reported (10), when Ca V 1.2a/␤/␣ 2 ␦ channels were compared with Ca V 1.2a/␤ channels.
The neuroendocrine Ca V 1.3 channel examined here yielded, on average, relatively low current amplitudes as compared with channels formed by the Ca V 2.2 and Ca V 1.2a subunits in the same expression system. Furthermore, the time interval after cRNA injection that was necessary to obtain currents of sufficient amplitude for kinetic analysis was longer than that required for the other ␣ 1 subunits. Reasons for this observation may be inherent to the Ca V 1.3 subunit itself. As suggested by Hofmann et al. (23) , one reason may be the need for additional, possibly still unidentified, auxiliary subunits. Another possible cause could be the necessity for specific interactions with additional proteins, as described for syntaxin and the Ca V 1.3a subunit in pancreatic ␤-cells (27) .
When the I-V curves for the neuroendocrine Ca V 1.3 channel used in the present study were analyzed, the maximum inward currents were found to occur at potentials between 0 and ϩ10 mV. A similar value of 0 mV was reported by Williams et al. (18) for a neuronal Ca V 1.3/␤ 2 /␣ 2 ␦ subunit combination expressed in Xenopus oocytes. A particularly interesting native cell for comparison in this respect is the rat pinealocyte, which has been shown to contain Ca V 1.3 as the sole calcium channel ␣ 1 subunit, together with the ␤ 2 and ␤ 4 subunits. The minimum of the I-V curve in these cells is also between 0 and 10 mV at similar Ba 2ϩ concentrations (26) . When comparing the potential dependence of the currents, it should be kept in mind that the ␤ subunit type also influences this property of calcium channels and, thus, the position of the I-V curve (23) . The comparison of the I-V minima, which we performed here, seems to be applicable, since at least in the case of the Ca V 2.1 subunit, ␤ 2 or ␤ 3 , the isoform used in the present study, had a similar influence on the potential dependence of the currents (30).
During prolonged depolarizations, the neuroendocrine Ca V 1.3 channel showed slow inactivation with Ba 2ϩ as the charge carrier. Inactivation was, however, on average twice as fast for the neuroendocrine Ca V 1.3 than for the cardiac Ca V 1.2a channel. The voltage dependence of inactivation also differed significantly between these two L-type channels, with the neuroendocrine Ca V 1.3 subtype inactivating at more negative membrane potentials. In mouse pancreatic ␤-cells, where the majority of the calcium current has been reported to be DHP-sensitive, inactivation during short voltage pulses was shown to be almost purely Ca 2ϩ -dependent (3). Other authors also reported a strong calcium-dependence in mouse pancreatic ␤-cells (45), but detected an additional slower voltagedependent component of HVA current inactivation when using longer depolarizing pulses and Ba 2ϩ as the charge carrier. The inactivation of the neuroendocrine Ca V 1.3 channel in our study, also using Ba 2ϩ as the charge carrier, could partially reflect this component. Although the Ca 2ϩ -dependent component dominates inactivation in ␤-cells, slower voltage-dependent inactivation could play a role in the regulation of calcium entry during slow wave depolarization.
Sensitivity to DHPs is a property that has frequently been used to distinguish the role of different calcium channel subtypes in the regulation of insulin secretion and the signal transduction processes in insulinsecreting cells (6, 46, 47) . Comparison of the DHP sensitivity of the neuroendocrine Ca V 1.3 and the cardiac Ca V 1.2a channel revealed similar IC 50 values for (ϩ)isradipine. Therefore, this DHP does not discriminate between these two channel isoforms.
Regulation of L-type calcium channels in insulinsecreting cells, either directly by heterotrimeric G proteins or through second messengers, is a matter of intense research (6, 42) . For instance, GPCRs have been reported to inhibit L-type calcium currents in insulin-secreting RINm5F cells via PT-sensitive G proteins (6, 7, 47) . Since heterologously expressed Ca V 1.2 (␣ 1C ) calcium channels are not a target for G protein-dependent inhibition (9, 35), Ca V 1.3 (␣ 1D ) isoforms are L-type channel candidates for inhibition by G proteins. However, in the present study, activation of PT-sensitive G proteins by -opioid receptors did not result in inhibition of the neuroendocrine calcium channel (Ca V 1.3 or ␣ 1D ) despite clear inhibition of the neuronal calcium channel (Ca V 2.2 or ␣ 1B ) under identical experimental conditions. In this context it should be noted that the Ca V 2.2 contains the known G␤␥-binding motif QXXER present in the intracellular loop between repeats I and II. Resequencing of the Ca V 1.3 by us revealed the presence of a QXXEE-amino acid motif in the loop I-II sequence, which has been found in various L-type calcium channels including a neuronal isoform known not to be directly inhibited by G␤␥ (23, 39, 48) .
In contrast, we found that currents through this Ca V 1.3 channel were increased after receptor activation. The stimulation of the Ca V 1.3 channel is clearly distinguishable from that of the endogenous channel both in time course and amplitude. The finding that the specific kinase inhibitors H7 and bisindolylmaleimide I abolished this receptor-induced current stimulation is mechanistically relevant and points to the involvement of a kinase. Stimulation of voltage-dependent calcium channels by PKC or PKA is well established (23) . H7 inhibits both kinases with IC 50 values in a comparable range whereas bisindolylmaleimide I is a potent inhibitor of PKC (43, 49) . Furthermore, we recently showed that smooth muscle L-type calcium channels are activated by G␤␥-subunits via PKC-and PI3K-dependent pathways (50, 51) . However, for GPCR-controlled regulation of the Ca V 1.3 channel examined in this study, the involvement of PI3K is unlikely, since the specific PI3K inhibitor wortmannin did not affect receptor-induced stimulation of the Ca V 1.3 channel at a concentration known to block class I PI3Ks (data not shown). Also, the involvement of PKA in transmitting the stimulatory activity from the receptor to the Ca V 1.3 channel is unlikely based on independent and complementary experimental approaches. First, we ascertained that the human -opioid receptor used in the present study couples exclusively to members of the G i /G o family but not to G s proteins, which are upstream activators of adenylyl cyclases and PKA (37). This selective coupling between the receptor and G proteins was independent of the ligand used. Second, a stimulation by the downstream effector PKA was ruled out by using the PKA inhibitor Rp-cAMPS. In contrast, several considerations argue for an involvement of PKC in stimulation of the Ca V 1.3 channel by the G i /G ocoupled -opioid receptor. It is well documented that PKC is activated by PT-sensitive GPCRs via G i /G o proteins and phospholipase C (for review see Ref. 52) . Accordingly, we confirmed that the -opioid receptor expressed in Xenopus oocytes was able to activate a calcium-dependent chloride current under appropriate experimental conditions. This stimulatory effect in Xenopus oocytes is an established read-out system to detect coupling between receptors and endogenous phospholipase C, the key regulator of PKC (53) . We also confirmed in a more direct fashion the ability of PKC to stimulate the Ca V 1.3 channel using the PKC activator PMA. Accordingly, recent studies described a stimulation of L-type calcium channel currents due to phosphorylation by PKC in the insulin-secreting cell lines HIT-T15 and RINm5F (42, 46).
In conclusion, the present study provides the first detailed description of a Ca V 1.3 (L-type ␣ 1D ) calcium channel subunit cloned from an insulin-producing cell line. The importance of L-type channels for the exocytotic process has been stressed by several authors (5, 54) . It is therefore interesting that the neuroendocrine Ca V 1.3 and the cardiac Ca V 1.2a Ltype channel subtypes, which are often coexpressed, as in insulin-secreting cells (19, 20) , display significant differences with respect to specific biophysical properties. Differences in the kinetics of channel activation and inactivation suggest that the two channels may have different roles during depolarization-induced calcium influx in ␤-cells and consequently in insulin secretion. Most interestingly, this Ca V 1.3 isoform is stimulated by GPCRs in a protein kinase-dependent manner.
MATERIALS AND METHODS
Chemicals
DAMGO was purchased from RBI (Natick, MA); H7 [(Ϯ)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine, 2 HCl] was from Tocris Cookson (Bristol, U.K.); and Rp-cAMPS was obtained from Calbiochem (Bad Soden, Germany). Stocks of those substances were prepared using double distilled water and stored at Ϫ20 C. The dihydropyridine (ϩ)isradipine (R(ϩ)-enantiomer of PN200-110) was a kind gift from Sandoz Pharmaceuticals Corp. (Basle, Switzerland). The stock solution of this substance was prepared with dimethylsulfoxide (DMSO). Collagenase type 1A and wortmannin were from Sigma-Aldrich Corp. (Deisenhofen, Germany). Wortmannin was stored in DMSO in the dark at Ϫ20 C. The calcium chelators BAPTA and the membrane permeable derivative BAPTA-AM were dissolved in a Tris-containing buffer (pH 7.2) or in DMSO and stored under N 2 , respectively. Phorbol-12-myristate-13-acetate (PMA) and bisindolylmalimide I [3-(N-[dimethylamino] propyl-3-indolyl)-4-(3-indolyl) maleimide] were from Sigma (St. Louis, MO), and the stock solutions were prepared with DMSO. All other chemicals were of highest purity available.
Expression Plasmids and Oocyte Preparation
The identity of the Ca V 1.3 clone was verified by sequencing. 1 After the addition of an artificial nucleotide sequence that was constructed to optimize translation, the coding sequence started at position 9 of the original amino acid sequence (19) (56)] were synthesized from the respective cDNAs using the mMessage mMachine in vitro transcription kit (Ambion, Inc. Austin, TX). Stage V-VI oocytes were surgically removed from adult female Xenopus laevis toads (African Xenopus Facility, Knysa, Republic of South Africa) anesthetized with 3-aminobenzoic acid ethyl ester (0.1% wt/vol) according to protocols approved by state and institutional regulations. The incision was sutured immediately after removal of the oocytes and the animals returned to the tank after recovery from surgery. They were then allowed to recover for at least 6 months before being reused as oocyte donors. Follicular cell-free oocytes were obtained by enzymatic isolation using collagenase type 1A (2 mg/ml) in Ca 2ϩ -free Barth's solution (in mM: NaCl, 88; KCl, 1; NaHCO 3 , 2.4, MgSO 4 , 0.82; HEPES, 10; pH 7.4 with NaOH) for 2 h and then stored in Ca 2ϩ -containing Barth's solution (in mM: NaCl, 88; KCl, 1; NaHCO 3 , 2.4; MgSO 4 , 0.82; HEPES, 10; CaCl 2 , 0.41; Ca(NO 3 ) 2 , 0.33; pH 7.4 with NaOH) supplemented with 2.5 mM sodium pyruvate, 0.1% wt/vol BSA, and 100 g/ml gentamycin at 18 C. The oocytes were allowed to recover for 24 h and then injected with the same relative proportions of the appropriate cRNAs at a concentration of 0.1 g/l. Using a Nanoject Oocyte Injector (Drummond Scientific Co., Broomall, PA), 50 nl of cRNA mixture were injected per oocyte. Barth's solution was renewed daily and cells were used on days 2-7 after injection, depending on the measured current amplitudes and the quality of the oocytes.
For clarity, the following synonyms were used for the respective injected subunit combinations: neuroendocrine calcium channel for Ca V 1.3/␤ 3 /␣ 2 ␦, cardiac Ca V 1.2a calcium channel for Ca V 1.2a/␤ 3 /␣ 2 ␦, endogenous oocyte calcium channel for ␤ 3 /␣ 2 ␦, and neuronal calcium channel for Ca V 2.2/␤ 3 /␣ 2 ␦.
Electrophysiological Recording
Two-electrode voltage-clamp currents were recorded using an Oocyte clamp OC-725A amplifier (Warner Instrument Corp., Hamden, CT). Voltage commands were generated and currents recorded using a personal computer interfaced with an TL-1 DMA Interface (Axon Instruments, Foster City, CA) to the amplifier and using the pClamp version 6 software (Axon Instruments). Microelectrodes were filled with 3 M KCl and had typical resistances of 0.5-2.5 M⍀. The bath was connected to the clamp circuit via a 3 M KCl-agar bridge. The bath solution contained in mM: Ba(OH) 2 , 35, NaOH, 50; HEPES, 10; pH 7.4 with methanesulfonic acid. Ba 2ϩ was used as the charge carrier in all calcium channel experiments. For experiments on calcium-dependent chloride currents, modified frog Ringer (in mM: NaCl, 90; KCl, 2.5; CaCl 2 , 1.8; HEPES, 10; pH 7.4 with NaOH) was used. Throughout all experiments, including drug applications, the bath was continuously perfused with solution at a rate of 2 ml/min. Oocytes were clamped at a holding potential of Ϫ60 mV, in the case of the steady-state inactivation experiments it was Ϫ80 mV. Only those recordings were used where currents could be adequately voltage clamped. For all experiments conducted with Ca V 1.3, Ca V 1.2a, or Ca V 2.2-calcium channels, at least five control oocytes injected with a corresponding amount of ␣ 2 ␦ and ␤ 3 cRNA were measured on the same day. Only those oocyte batches were used for analysis for which the resulting endogenous calcium current in control oocytes comprised less than 20% of the total inward barium current in oocytes expressing the exogenous channels. In the case of experiments where current kinetics were determined, the maximum endogenous currents were Ͻ20% of the total current. Only those experiments were considered for final analysis that showed inward holding currents of less than 10% of the maximum inward current and only minimal fluctuations during the course of the experiment.
Data Analysis and Presentation
Where appropriate, values are given as means Ϯ SE. Statistical significance was evaluated by one-way ANOVA, and individual P values are given. The term n represents the number of oocytes tested. Curve fitting was done by a leastsquares minimization method using the following equations. For I-V curves:
where g is the maximum conductance, V t the test potential, E the apparent reversal potential, V 1/2 the potential of halfactivation, and k a slope factor. For steady-state inactivation curves,
where V p is the prepulse potential, C a baseline, and I has inactivated by half at the prepulse potential indicated by V 1/2 with an e-fold change over k mV. For determination of channel activation from tail currents, respectively, where is the time (t) at which the current had decreased to 1/e of its initial amplitude, A is the maximal amplitude of the component, and C is the steady-state current levels. Dose-response curves for (ϩ)isradipine were fitted applying Iϭ1 Ϫ f͕1/͓1ϩ͑IC 50 /c͒ n ͔͖
where f represents the maximal fraction of current responsive to the substance, which was calculated by subtracting the relative contribution of endogenous inward Ba 2ϩ current from total inward current. The IC 50 value is the substance concentration resulting in half-maximal current inhibition, and c is the substance concentration tested. The Hill coefficient, n, was set to 1. When normalized data were fitted, the same equations apply for I/I max .
DAMGO was used to activate the -opioid receptor expressed after coinjection of its cRNA. The resulting effect on each current was calculated between the last data point before agonist application and the point of maximal effect. Current run-down was not taken into account. 
